Policy implications of the changing epidemiology of chagas disease and stroke

Stroke

Volumn 44, Issue 8, 2013, Pages 2356-2360

  Carod Artal, Francisco Javier ^a,b  

^a RAIGMORE HOSPITAL   (United Kingdom)

^b UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

Chagas disease; policy, stroke; Trypanosoma cruzi

Indexed keywords

BENZNIDAZOLE; NIFURTIMOX;

AGING; ARTICLE; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHAGAS DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ENCEPHALITIS; HEALTH CARE POLICY; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; IMMIGRANT; MIGRATION; MYOCARDITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANT WOMAN; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HEALTH PROBLEM; SOUTH AND CENTRAL AMERICA; THROMBOEMBOLISM; THROMBUS; TRANSCRANIAL DOPPLER; TRYPANOSOMA CRUZI; VECTOR CONTROL; WESTERN HEMISPHERE;

CHAGAS DISEASE; POLICY, STROKE; TRYPANOSOMA CRUZI;

CHAGAS DISEASE; HUMANS; STROKE;

EID: 84880819310     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.000738     Document Type: Article

References (23)

1. Basile L, Jansa JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, et al.; Working Group on Chagas Disease. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011 Sep 15;16:19968.
2. Carod-Artal FJ, Gascon J. Chagas disease and stroke. Lancet Neurol. 2010;9:533-542.
3. World Health Organization (WHO). Working to Overcome the Global Impact of Neglected Tropical Diseases: First WHO Report on Neglected Tropical Diseases. Geneva: WHO; 2010. Report No.: WHO/HTM/NTD/2010.1
4. Carod-Artal FJ, Ribeiro Lda S, Vargas AP. Awareness of stroke risk in chagasic stroke patients. J Neurol Sci. 2007;263:35-39. (Pubitemid 350029825)
5. Carod-Artal FJ, Vargas AP, Melo M, Horan TA. American trypanoso-miasis (Chagas' disease): an unrecognised cause of stroke. J Neurol Neurosurg Psychiatr. 2003;74:516-518. (Pubitemid 36379381)
6. Lescure FX, Le Loup G, Freilij H, Develoux M, Paris L, Brutus L, et al. Chagas disease: changes in knowledge and management. Lancet Infect Dis. 2010;10:556-570.
7. Brutus L, Castillo H, Bernal C, Salas NA, Schneider D, Santalla JA, et al. Detectable Trypanosoma cruzi parasitemia during pregnancy and delivery as a risk factor for congenital Chagas disease. Am J Trop Med Hyg. 2010;83:1044-1047.
8. Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 2013;13:342-348.
9. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14-21.
10. Sicuri E, Muñoz J, Pinazo MJ, Posada E, Sanchez J, Alonso PL, et al. Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area. Acta Trop. 2011;118:110-117.
11. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009;49:e52-e54.
12. Cantey PT, Stramer SL, Townsend RL, Kamel H, Ofafa K, Todd CW, et al. The United States Trypanosoma cruzi Infection Study: evidence for vector-borne transmission of the parasite that causes Chagas disease among United States blood donors. Transfusion. 2012;52: 1922-1930.
13. Oliveira-Filho J, Viana LC, Vieira-de-Melo RM, Faiçal F, Torreão JA, Villar FA, et al. Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas Disease cohort. Stroke. 2005;36: 2015-2017. (Pubitemid 41266544)
14. Paixão LC, Ribeiro AL, Valacio RA, Teixeira AL. Chagas disease: independent risk factor for stroke. Stroke. 2009;40:3691-3694.
15. Carod-Artal FJ, Vargas AP, Horan TA, Nunes LG. Chagasic cardiomyop-athy is independently associated with ischemic stroke in Chagas disease. Stroke. 2005;36:965-970. (Pubitemid 40629285)
16. Carod-Artal FJ, Vargas AP, Falcao T. Stroke in asymptomatic Trypanosoma cruzi-infected patients. Cerebrovasc Dis. 2011;31:24-28.
17. Nunes MC, Barbosa MM, Ribeiro AL, Barbosa FB, Rocha MO. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study. J Neurol Sci. 2009;278:96-101.
18. Lima-Costa MF, Matos DL, Ribeiro AL. Chagas disease predicts 10-year stroke mortality in community-dwelling elderly: the Bambui cohort study of aging. Stroke. 2010;41:2477-2482.
19. Rassi A Jr, Rassi A, Rassi SG. Predictors of mortality in chronic Chagas disease: a systematic review of observational studies. Circulation. 2007;115:1101-1108. (Pubitemid 46673172)
20. Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, et al.; BENEFIT Investigators. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J. 2008;156:37-43. (Pubitemid 351862295)
21. Trabuco CC, Pereira de Jesus PA, Bacellar AS, Oliveira-Filho J. Successful thrombolysis in cardioembolic stroke from Chagas disease. Neurology. 2005;64:170-171. (Pubitemid 40082968)
22. Di Girolamo C, Bodini C, Marta BL, Ciannameo A, Cacciatore F. Chagas disease at the crossroad of international migration and public health policies: why a national screening might not be enough. Euro Surveill. 2011 Sep 15;16:19965.
23. Armaganijan L, Morillo CA. Chagas disease: 101 years of solitude! Time for action. Stroke. 2010;41:2453-2454.